Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer

NCT00630695 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT00630695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer
Lead sponsor
University Hospital, Limoges
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2011
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphocele